Euclid Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-57,331
Closed -$4.47M 89
2016
Q2
$4.47M Sell
57,331
-6,770
-11% -$540K 0.19% 178
2016
Q1
$5.25M Sell
64,101
-60,674
-49% -$4.93M 0.2% 174
2015
Q4
$11.1M Buy
+124,775
New +$10.6M 0.34% 92
2015
Q3
Sell
-207,020
Closed -$17.3M 257
2015
Q2
$17.3M Buy
207,020
+85,150
+70% +$7.52M 0.34% 89
2015
Q1
$11M Buy
+121,870
New +$10.5M 0.2% 121
2014
Q4
Sell
-172,930
Closed -$13M 387
2014
Q3
$13M Buy
172,930
+8,580
+5% +$624K 0.09% 199
2014
Q2
$11.3M Sell
164,350
-26,808
-14% -$1.83M 0.08% 250
2014
Q1
$13.4M Buy
191,158
+53,770
+39% +$3.74M 0.1% 182
2013
Q4
$9.18M Sell
137,388
-6,170
-4% -$377K 0.08% 244
2013
Q3
$7.49M Buy
143,558
+28,260
+25% +$1.44M 0.08% 240
2013
Q2
$5.44M Buy
+115,298
New +$5.27M 0.07% 281

Other funds holding CAH

Euclid Advisors's CAH Position: Q3 2016 in Review

Euclid Advisors sold out of Cardinal Health (CAH) in Q3 2016, closing a stake of 57,331 shares — an estimated $4.47M sold.

Euclid Advisors first reported a position in CAH in Q2 2013 and held it in 11 quarters. The position peaked at $17.3M in Q2 2015. 772 funds tracked by Wall St. Rank hold CAH as of Q3 2016.

  • Euclid Advisors reported no remaining Cardinal Health position as of Q3 2016 after selling out during the quarter.
  • Euclid Advisors sold 57,331 Cardinal Health shares in Q3 2016, an estimated $4.47M.
  • Euclid Advisors first reported a position in Cardinal Health in Q2 2013 and held it in 11 quarters.
  • Euclid Advisors's Cardinal Health position peaked at $17.3M in Q2 2015.
  • 772 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.